Filling the need for trusted information on national health issues…

Access to Health Services

  • Your Selections:

Refine Results



Advocacy Groups Warn Trans-Pacific Partnership Could Affect Access To Low-Cost Medications, Bloomberg Reports

Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. “Protecting the patents of drug makers … as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen,” and “[t]he proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations,” the news service writes. “The multilateral talks, the main accord being pursued by President Barack Obama’s administration, … began with Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore, the U.S. and Vietnam [and] may expand after the parties invited Canada and Mexico,” the news service notes.

Syrians In Urgent Need Of Life-Saving Medicines As Fighting Escalates, WHO Warns

“Syrians are in urgent need of life-saving medicines following an escalation in fighting, which also threatens further food shortages, U.N. agencies warned on Tuesday,” Agence France-Presse reports (8/7). “Drugs for tuberculosis, hepatitis, hypertension, diabetes and cancer are urgently needed, as well as hemodialysis for kidney diseases, according to the WHO,” Reuters notes (8/7). “‘The recent escalation of clashes had resulted in substantial damages to the pharmaceutical plants located in rural Aleppo, Homs and Rural Damascus, where 90 percent of the country’s plants were located,’ a WHO spokesperson, Tarik Jasarevic, told reporters in Geneva today,” the U.N. News Centre writes. “Prior to the violence which has wracked the Middle Eastern country, Syria produced 90 percent of its medicines and drugs locally,” the news service notes (8/7).

GeneXpert TB Test Maker Cepheid Signs Deals With PEPFAR, USAID, Others To Provide Lower-Cost Kits

Diagnostics company Cepheid on Monday signed deals with PEPFAR, USAID, UNITAID, and the Bill & Melinda Gates Foundation to immediately reduce the price of its Xpert MTB/RIF test kit for its GeneXpert tuberculosis (TB) diagnostic system in 145 countries, Reuters reports. “The agreements will see the test sold for $9.98, down from its current price of $16.86 per test,” the news service writes, adding, “Cepheid said the Bill & Melinda Gates Foundation will make an initial payment of $3.5 million to make the test immediately available at the lower price” (Ail, 8/6).

Trans-Pacific Partnership Trade Agreement Could Restrict Access To Affordable, Life-Saving Drugs

In this post in the PLoS “Speaking of Medicine” blog, Judit Rius Sanjuan, a lawyer from Barcelona, Spain, and the U.S. manager of the Access Campaign at Medecins Sans Frontieres (MSF), says the Trans-Pacific Partnership (TPP), a regional trade agreement that currently involves 11 countries but could expand to include other countries in the Asia-Pacific region, “threatens to set a dangerous precedent with damaging implications for developing countries where MSF works, and beyond.” “Negotiations are being conducted in secret, but leaked drafts of the agreement outline U.S. aggressive intellectual property (IP) demands that that could severely restrict access to affordable, life-saving medicines for millions of people,” she writes, concluding, “At this pivotal moment in the fight against AIDS, when the scientific, medical and policy tools needed to reverse the epidemic are finally at hand, … the U.S. government’s demands in the TPP will threaten so much of what has been achieved so far, and will make the vision of an AIDS-free generation impossible, or at least much more expensive” (8/7).

Health Worker Training Program In Tanzania's Kigoma Region Reducing Maternal Mortality Rate

Inter Press Service reports on the successful efforts of Tanzania’s Kigoma Region “to train assistant medical officers to conduct life-saving c-sections at its rural health centers,” allowing pregnant women with complications to deliver at more local facilities instead of having to travel to regional or district hospitals. Tanzania’s maternal mortality rate is high, at 578 deaths for every 100,000 live births, IPS notes. “[A]t one point the Kigoma Region had the highest rate in the country, at 933 per 100,000 live births in the early 1980s,” but “maternal mortality in this region [now] is considered to be lower than in the rest of the country,” according to the news service.

U.N. Urges Philippines To Pass Reproductive Health Bill Amid Protests From Catholic Church

“The United Nations has urged the Philippines to pass a bill that will allow the government to provide free contraceptives,” BBC News reports (8/5). “UNFPA country coordinator Ugochi Florence Daniels said the [reproductive health (RH)] bill is important for the Philippines to achieve its health-related targets in the Millennium Development Goals (MDGs),” including maternal health, HIV/AIDS and infant mortality, the Philippine Star writes (Crisostomo, 8/4). “The House of Representatives plans to decide Tuesday whether to end debate on the bill and put it to a vote,” the Associated Press/Seattle Times notes (Gomez, 8/5).

Science Magazine Recaps Issues Discussed At AIDS 2012

Science looks back at the XIX International AIDS Conference (AIDS 2012), which ended last week in Washington, D.C., writing, “The battle against HIV is having more success than ever. … But several presentations made clear that a gulf separates aspirations from reality when it comes to ‘ending AIDS,’ which [Secretary of State Hillary] Clinton and many other prominent speakers at the conference emphasized was now possible.” Though more people are on antiretrovirals (ARVs) now than ever, low- and middle-income countries are spending more on HIV/AIDS, and “attempts to find a cure — long viewed as a fantasy — now lead the scientific agenda,” most “of the 34 million HIV-infected people in the world do not take ARVs, many receiving treatment have trouble staying on the medication, … new infection rates continue to climb in key populations,” “[n]o AIDS vaccine is on the horizon,” and “funding shortfalls loom for global programs,” Science writes, quoting several speakers at the conference and providing more detail on the successes and challenges in the response against HIV/AIDS (Cohen, 8/3).

U.S. Announces Additional $12M In Humanitarian Aid To Syria

“The United States announced Thursday it would hike its humanitarian aid to Syria, adding another $12 million to provide food, water, medicine and other necessities for battered and displaced people” affected by violence in the Syrian conflict, the Los Angeles Times blog “World Now” reports. “The increase approved by the Obama administration brings American humanitarian assistance in Syria to more than $76 million, including $27.5 million to the World Food Programme [WFP], roughly $18 million for the United Nations refugee agency and the rest split among other U.N. funds and non-profit groups,” the blog writes (Alpert, 8/2).

Widespread Use Of Current Technologies 'Essential' To Improve Global Health

Noting that this week’s issue of the Lancet explores the theme of “[a]ccess to beneficial health technology, including essential medicines and medical devices, for those most in need,” a Lancet editorial states, “Maximizing use of current health technologies (drugs, devices, biological products, medical and surgical procedures, support systems, and organizational systems) is essential to improving global health.” Collaboration between the journal and Imperial College London has resulted in a new Commission on technologies for global health, which examines different ways to broaden the use of new technologies, from bringing down cost to making them more culturally acceptable, the editorial notes.

Two GAO Reports Focus On Global Health Issues

The U.S. Government Accountability Office (GAO) recently released two reports on issues related to global health. In “Ensuring Drug Quality in Global Health Programs,” the agency writes, “Concerns have been raised about the potential for substandard drugs to enter the supply chains of global health programs,” and notes that it concluded, “U.S.-funded global health programs have put regulatory and policy requirements in place to help prevent procurement of substandard drugs” (8/1). In another report looking at the WHO, titled “Reform Agenda Developed, but U.S. Actions to Monitor Progress Could be Enhanced,” GAO found, “The United States has provided input into WHO’s reform agenda, particularly in the areas of transparency and accountability, but the Department of State’s (State) tool for assessing progress in the area of management reform could be enhanced” (7/23).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.